መነሻ › Multiple Sclerosis › ከንታኪ
በከንታኪ ለMultiple Sclerosis የሚደረጉ ክሊኒካዊ ጥናቶች
ለMultiple Sclerosis የሚደረጉ 3 ጥናቶች በከንታኪ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
Official study text (English)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kentucky/Markey Cancer Center, Lexington
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Lexington
- TG Therapeutics Investigational Trial Site, Louisville
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT06433752Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- University of Louisville, Norton Children's Research Institute, Louisville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ10 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06408259ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።